PMC:7278327 / 987-1291 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T9","span":{"begin":149,"end":157},"obj":"Body_part"},{"id":"T10","span":{"begin":201,"end":204},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma278683"}],"text":"Genetic engineering of the RABV has been employed to generate novel vaccines consisting of non-replicating RABV particles expressing chimeric capsid proteins containing human immunodeficiency virus 1 (HIV-1), Middle East respiratory syndrome (MERS-CoV), Ebolavirus, and hepatitis C virus (HCV) sequences."}

{"project":"LitCovid-PubTator","denotations":[{"id":"37","span":{"begin":243,"end":251},"obj":"Species"},{"id":"38","span":{"begin":270,"end":287},"obj":"Species"},{"id":"41","span":{"begin":27,"end":31},"obj":"Species"},{"id":"42","span":{"begin":107,"end":111},"obj":"Species"},{"id":"43","span":{"begin":289,"end":292},"obj":"Species"},{"id":"51","span":{"begin":175,"end":241},"obj":"Disease"}],"attributes":[{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"Tax:1335626"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"Tax:11103"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"Tax:11292"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"Tax:11292"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"Tax:11103"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"MESH:D018352"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Genetic engineering of the RABV has been employed to generate novel vaccines consisting of non-replicating RABV particles expressing chimeric capsid proteins containing human immunodeficiency virus 1 (HIV-1), Middle East respiratory syndrome (MERS-CoV), Ebolavirus, and hepatitis C virus (HCV) sequences."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T13","span":{"begin":175,"end":191},"obj":"Disease"},{"id":"T14","span":{"begin":270,"end":281},"obj":"Disease"},{"id":"T15","span":{"begin":270,"end":279},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0021094"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0005231"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"}],"text":"Genetic engineering of the RABV has been employed to generate novel vaccines consisting of non-replicating RABV particles expressing chimeric capsid proteins containing human immunodeficiency virus 1 (HIV-1), Middle East respiratory syndrome (MERS-CoV), Ebolavirus, and hepatitis C virus (HCV) sequences."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T17","span":{"begin":32,"end":35},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T18","span":{"begin":169,"end":174},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T19","span":{"begin":192,"end":197},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T20","span":{"begin":282,"end":287},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"Genetic engineering of the RABV has been employed to generate novel vaccines consisting of non-replicating RABV particles expressing chimeric capsid proteins containing human immunodeficiency virus 1 (HIV-1), Middle East respiratory syndrome (MERS-CoV), Ebolavirus, and hepatitis C virus (HCV) sequences."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T4","span":{"begin":149,"end":157},"obj":"Chemical"}],"attributes":[{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Genetic engineering of the RABV has been employed to generate novel vaccines consisting of non-replicating RABV particles expressing chimeric capsid proteins containing human immunodeficiency virus 1 (HIV-1), Middle East respiratory syndrome (MERS-CoV), Ebolavirus, and hepatitis C virus (HCV) sequences."}

{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":0,"end":304},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Genetic engineering of the RABV has been employed to generate novel vaccines consisting of non-replicating RABV particles expressing chimeric capsid proteins containing human immunodeficiency virus 1 (HIV-1), Middle East respiratory syndrome (MERS-CoV), Ebolavirus, and hepatitis C virus (HCV) sequences."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":175,"end":191},"obj":"Phenotype"},{"id":"T2","span":{"begin":270,"end":279},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002721"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"Genetic engineering of the RABV has been employed to generate novel vaccines consisting of non-replicating RABV particles expressing chimeric capsid proteins containing human immunodeficiency virus 1 (HIV-1), Middle East respiratory syndrome (MERS-CoV), Ebolavirus, and hepatitis C virus (HCV) sequences."}